| The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma TN Aladily, A Mansour, A Alsughayer, M Sughayer, LJ Medeiros Annals of Diagnostic Pathology 40, 72-76, 2019 | 17 | 2019 |
| Comparison of 22C3 PharmDx and SP263 assays to test PD-L1 expression in NSCLC MA Sughayer, F Alnaimy, AM Alsughayer, N Qamhia Applied Immunohistochemistry & Molecular Morphology 27 (9), 663-666, 2019 | 12 | 2019 |
| The clinicopathological features of programmed death ligand-1 expression in colorectal carcinoma GN Al-Jussani, A Alsughayer, MS Yousuf, Y Mullahuwash, T Dabbagh, ... The International Journal of Biological Markers 37 (3), 322-327, 2022 | 7 | 2022 |
| Changing trends in estrogen receptors/progesterone receptors/human epidermal growth factor receptor 2 prevalence rates among Jordanian patients with breast cancer over the years AM Alsughayer, TZ Dabbagh, RH Abdel-Razeq, GN Al-Jussani, ... JCO global oncology 8, e2100359, 2022 | 3 | 2022 |
| The utility of fascin and CD83 in the differential diagnosis of mediastinal large B-cell lymphomas M Khader, TN Aladily, M Sughayer, A Alsughayer, RN Miranda, ... VIRCHOWS ARCHIV 469 (SUPPL 1), S111-S111, 2016 | 2 | 2016 |
| A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity? MA Sughayer, A Mansour, AA Nuirat, L Souan, R Abdel-Razeq, M Siag medRxiv, 2021.08. 15.21261584, 2021 | 1 | 2021 |
| The Value of Virtual Meetings during COVID-19 Pandemic in Healthcare Settings MA Sughayer, TZ Dabbagh, L Souan, A Alsughayer American Journal of Clinical Pathology 158 (Supplement_1), S127-S127, 2022 | | 2022 |
| Changing trends in hormone receptor and Her2 rates in breast cancer overtime M Sughayer, H Abdel-Razeq, G Al-Jussania, A Alsughayer, T Dabbagh, ... VIRCHOWS ARCHIV 479 (SUPPL 1), S73-S74, 2021 | | 2021 |
Maher Sughayer MD, FCAPfull member and chairman, King Hussein Cancer CenterVerified email at khcc.jo
Maher Sughayer MD, FCAPfull member and chairman, King Hussein Cancer CenterVerified email at khcc.jo